BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18804834)

  • 1. Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines.
    Chen Z; Aspelund A; Kemble G; Jin H
    Virology; 2008 Oct; 380(2):354-62. PubMed ID: 18804834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist).
    Chen Z; Aspelund A; Kemble G; Jin H
    Virology; 2006 Feb; 345(2):416-23. PubMed ID: 16289204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.
    Chan W; Zhou H; Kemble G; Jin H
    Virology; 2008 Oct; 380(2):304-11. PubMed ID: 18768193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.
    Hoffmann E; Mahmood K; Chen Z; Yang CF; Spaete J; Greenberg HB; Herlocher ML; Jin H; Kemble G
    J Virol; 2005 Sep; 79(17):11014-21. PubMed ID: 16103152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Drieszen-van der Cruijsen SK; Basten SM; Heldens JG; van den Bosch H; Rudenko LG
    J Gen Virol; 2010 Apr; 91(Pt 4):931-7. PubMed ID: 20007357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.
    Jin H; Lu B; Zhou H; Ma C; Zhao J; Yang CF; Kemble G; Greenberg H
    Virology; 2003 Feb; 306(1):18-24. PubMed ID: 12620793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).
    Isakova-Sivak I; Chen LM; Matsuoka Y; Voeten JT; Kiseleva I; Heldens JG; den Bosch Hv; Klimov A; Rudenko L; Cox NJ; Donis RO
    Virology; 2011 Apr; 412(2):297-305. PubMed ID: 21315402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).
    Cox NJ; Kitame F; Kendal AP; Maassab HF; Naeve C
    Virology; 1988 Dec; 167(2):554-67. PubMed ID: 2974219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.
    Buonagurio DA; Bechert TM; Yang CF; Shutyak L; D'Arco GA; Kazachkov Y; Wang HP; Rojas EA; O'Neill RE; Spaete RR; Coelingh KL; Zamb TJ; Sidhu MS; Udem SA
    Vaccine; 2006 Mar; 24(12):2151-60. PubMed ID: 16413951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.
    An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL
    Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo.
    Crescenzo-Chaigne B; Naffakh N; van der Werf S
    Virology; 1999 Dec; 265(2):342-53. PubMed ID: 10600605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering of live attenuated influenza viruses.
    Jin H; Chen Z; Liu J; Kemble G
    Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.
    White CL; Chiem K; Perez DR; Santos J; Cardenas Garcia S; Nogales A; Martínez-Sobrido L
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34208979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
    Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
    Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping and screening of reassortant live-attenuated influenza B vaccine strain.
    Lee EY; Lee KH; Jung EJ; Jang YH; Seo SU; Kim HA; Seong BL
    J Virol Methods; 2010 May; 165(2):133-8. PubMed ID: 19883691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: independent segregation of temperature-sensitivity of virus replication from temperature-sensitivity of virion transcriptase activity during recombination of mutant A/Ann Arbor/6/60 with wild-type H3N2 strains.
    Kendal AP; Cox NJ; Galphin JC; Maassab HF
    J Gen Virol; 1979 Aug; 44(2):443-56. PubMed ID: 521798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation and phenotypic stability of influenza B/Texas/1/84 cold-adapted reassortant virus: studies in hamsters and chimpanzees.
    Snyder MH; London WT; Maassab HF; Murphy BR
    J Infect Dis; 1989 Oct; 160(4):604-10. PubMed ID: 2794557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.